|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mihaly Z, Sztupinszki Z, Surowiak P and
Gyorffy B: A comprehensive overview of targeted therapy in
metastatic renal cell carcinoma. Curr Cancer Drug Targets.
12:857–872. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pittenger MF, Kazzaz JA and Helfman DM:
Functional properties of non-muscle tropomyosin isoforms. Curr Opin
Cell Biol. 6:96–104. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brown JH, Kim KH, Jun G, et al:
Deciphering the design of the tropomyosin molecule. Proc Natl Acad
Sci USA. 98:8496–8501. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perry SV: Vertebrate tropomyosin:
distribution, properties and function. J Muscle Res Cell Motil.
22:5–49. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bharadwaj S and Prasad GL: Tropomyosin-1,
a novel suppressor of cellular transformation is downregulated by
promoter methylation in cancer cells. Cancer Lett. 183:205–213.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mlakar V, Berginc G, Volavsek M, Stor Z,
Rems M and Glavac D: Presence of activating KRAS mutations
correlates significantly with expression of tumour suppressor genes
DCN and TPM1 in colorectal cancer. BMC Cancer. 9:2822009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Zhang R, Wu D, et al: Epigenetic
change in kidney tumor: downregulation of histone acetyltransferase
MYST1 in human renal cell carcinoma. J Exp Clin Cancer Res.
32:82013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Venerito M, Treiber G, Wex T, et al:
Effects of low-dose aspirin on gastric erosions, cyclooxygenase
expression and mucosal prostaglandin-E2 do not depend on
Helicobacter pylori infection. Aliment Pharmacol Ther.
23:1225–1233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong W, Zhang H, Li J, et al: Estrogen
induces metastatic potential of papillary thyroid cancer cells
through estrogen receptor α and β. Int J Endocrinol.
2013:9415682013. View Article : Google Scholar
|
|
12
|
Petrova DT, Asif AR, Armstrong VW, et al:
Expression of chloride intracellular channel protein 1 (CLIC1) and
tumor protein D52 (TPD52) as potential biomarkers for colorectal
cancer. Clin Biochem. 41:1224–1236. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ku BM, Ryu HW, Lee YK, et al:
4′-Acetoamido-4-hydro-xychalcone, a chalcone derivative, inhibits
glioma growth and invasion through regulation of the tropomyosin 1
gene. Biochem Biophys Res Commun. 402:525–530. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yager ML, Hughes JA, Lovicu FJ, Gunning
PW, Weinberger RP and O’Neill GM: Functional analysis of the
actin-binding protein, tropomyosin 1, in neuroblastoma. Br J
Cancer. 89:860–863. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alaiya AA, Oppermann M, Langridge J, et
al: Identification of proteins in human prostate tumor material by
two-dimensional gel electrophoresis and mass spectrometry. Cell Mol
Life Sci. 58:307–311. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang W, Wang X, Zheng W, Li K, Liu H and
Sun Y: Genetic and epigenetic alterations are involved in the
regulation of TPM1 in cholangiocarcinoma. Int J Oncol. 42:690–698.
2013.
|
|
17
|
Tang HY, Beer LA, Tanyi JL, Zhang R, Liu Q
and Speicher DW: Protein isoform-specific validation defines
multiple chloride intracellular channel and tropomyosin isoforms as
serological biomarkers of ovarian cancer. J Proteomics. 89:165–178.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zare M, Jazii FR, Soheili ZS and
Moghanibashi MM: Down-regulation of tropomyosin-1 in squamous cell
carcinoma of esophagus, the role of Ras signaling and methylation.
Mol Carcinog. 51:796–806. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pawlak G, McGarvey TW, Nguyen TB, et al:
Alterations in tropomyosin isoform expression in human transitional
cell carcinoma of the urinary bladder. Int J Cancer. 110:368–373.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ficarra V, Martignoni G, Maffei N, et al:
Original and reviewed nuclear grading according to the Fuhrman
system: a multivariate analysis of 388 patients with conventional
renal cell carcinoma. Cancer. 103:68–75. 2005. View Article : Google Scholar
|
|
21
|
Klatte T, Anterasian C, Said JW, et al:
Fuhrman grade provides higher prognostic accuracy than nucleolar
grade for papillary renal cell carcinoma. J Urol. 183:2143–2147.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lees JG, Bach CT and O’Neill GM: Interior
decoration: tropomyosin in actin dynamics and cell migration. Cell
Adh Migr. 5:181–186. 2011. View Article : Google Scholar :
|
|
23
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bharadwaj S, Thanawala R, Bon G, Falcioni
R and Prasad GL: Resensitization of breast cancer cells to anoikis
by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and
adhesion. Oncogene. 24:8291–8303. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Faragalla H, Youssef YM, Scorilas A, et
al: The clinical utility of miR-21 as a diagnostic and prognostic
marker for renal cell carcinoma. J Mol Diagn. 14:385–392. 2012.
View Article : Google Scholar : PubMed/NCBI
|
